These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28061953)

  • 1. Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.
    Geadas C; Stoszek SK; Sherman D; Andrade BB; Srinivasan S; Hamilton CD; Ellner J
    Tuberculosis (Edinb); 2017 Jan; 102():55-67. PubMed ID: 28061953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative Tuberculosis Symposium held during Cuba Salud 2015.
    Chapman HJ; Armas Pérez L
    Tuberculosis (Edinb); 2016 Dec; 101():41-43. PubMed ID: 27865395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
    Marimani M; Ahmad A; Duse A
    Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To fight tuberculosis, fund basic research.
    Grundner C
    PLoS Biol; 2018 Sep; 16(9):e3000037. PubMed ID: 30252891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
    Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
    Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi India.
    Atmakuri K; Penn-Nicholson A; Tanner R; Dockrell HM
    Tuberculosis (Edinb); 2018 Dec; 113():55-64. PubMed ID: 30514514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Texas tuberculosis research symposium 2018: Research and clinical collaboration within the State of Texas - Moving towards elimination of TB.
    Dhandayuthapani S; Actor JK; Graviss EA
    Tuberculosis (Edinb); 2019 May; 116S():S1. PubMed ID: 31126719
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
    Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
    Front Immunol; 2020; 11():680. PubMed ID: 32411131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new vaccines and drugs for TB: limitations and potential strategic errors.
    Orme IM
    Future Microbiol; 2011 Feb; 6(2):161-77. PubMed ID: 21366417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blueprint for vaccine research & development: walking the path for better TB vaccines.
    Lienhardt C; Fruth U; Greco M
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S33-5. PubMed ID: 22441158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.
    Lienhardt C; Lönnroth K; Menzies D; Balasegaram M; Chakaya J; Cobelens F; Cohn J; Denkinger CM; Evans TG; Källenius G; Kaplan G; Kumar AM; Matthiessen L; Mgone CS; Mizrahi V; Mukadi YD; Nguyen VN; Nordström A; Sizemore CF; Spigelman M; Squire SB; Swaminathan S; Van Helden PD; Zumla A; Weyer K; Weil D; Raviglione M
    PLoS Med; 2016 Mar; 13(3):e1001965. PubMed ID: 26933883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis... Can we beat it? Report from a Euroscicon conference 2013.
    Maitra A; Bhakta S
    Virulence; 2013 Aug; 4(6):499-503. PubMed ID: 23863609
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis in Africa: learning from pathogenesis for biomarker identification.
    Kaufmann SH; Parida SK
    Cell Host Microbe; 2008 Sep; 4(3):219-28. PubMed ID: 18779048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis: drug resistance and future perspectives.
    Riccardi G; Pasca MR; Buroni S
    Future Microbiol; 2009 Jun; 4(5):597-614. PubMed ID: 19492969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Patient to Molecule: In Pursuit of Universal Treatments for TB.
    Heaton PM; Barrett JS
    Clin Transl Sci; 2020 Mar; 13(2):224-227. PubMed ID: 31782618
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis vaccines: a strategic blueprint for the next decade.
    Brennan MJ; Thole J
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S6-13. PubMed ID: 22441160
    [No Abstract]   [Full Text] [Related]  

  • 18. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
    Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
    Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
    Chae H; Shin SJ
    J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.